Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
AstraZeneca Pharma India Limited ( (IN:ASTRAZEN) ) has shared an announcement.
AstraZeneca Pharma India Limited has submitted a compliance certificate to the stock exchanges, confirming adherence to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This announcement underscores the company’s commitment to regulatory compliance, which is crucial for maintaining investor trust and ensuring smooth operations within the financial markets.
More about AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited operates in the pharmaceutical industry, focusing on the development and distribution of prescription medicines. The company is part of the global AstraZeneca group, which is known for its innovative treatments in areas such as oncology, cardiovascular, renal, and respiratory diseases.
Average Trading Volume: 3,633
Current Market Cap: 230.9B INR
For an in-depth examination of ASTRAZEN stock, go to TipRanks’ Overview page.